Genome Profiling, LLC ("GenPro")
Discovering and translating novel epigenetic biomarkers into high-throughput low-cost precision assays for patient stratification and early disease detection
- Stage $500K in TTM Revenue
- Industry Biotechnology
- Location Newark, DE, US
- Currency USD
- Founded June 2014
- Employees 5
- Incorporation Type LLC
- Website genprollc.com
GenPro is a molecular information company specializing in novel epigenetic biomarker (EpiMarkerTM) discovery from next generation sequencing data and the translation of EpiMarkers into high-throughput / low cost precision qPCR assays for patient stratification, early disease detection, companion diagnostics, diagnostics and new insights into genes, pathways, mechanisms of actions and new epigenetic targets across many diseases.
https://www.linkedin.com/in/jebconnor: With more than 25 years as CEO and Chairman of numerous successful investor-backed software and life-science technology companies, Mr. Connor brings proven company formation, capitalization, operational execution, growth, development, and exit leadership to GenPro. He is a hands-on customer-focused CEO that surrounds himself with outstanding teams aligned to a shared vision.
https://www.linkedin.com/in/adam-marsh-3060a916: Dr. Marsh is the visionary, inventor and leader of GenPro's core IP and analytics software. He also leads R&D and supports sales and client engagements. A pioneer in the field of computational epigenetics, he invented GenPro's underlying software technology while a faculty member in the Center for Bioinformatics and Computational Biology at the University of Delaware where he is a professor.
https://www.linkedin.com/in/didier-landais-7b795a6: Didier leads GenPro's customer-facing functions including business development, sales, marketing and project management. Didier brings to GenPro >25 years of relevant industrial and international biotech/biopharma industry experience and relationships where he served as an executive leader in R&D, project management, GMP manufacturing, and business development with an emphasis in oncology.
https://www.linkedin.com/in/mortgoldman: Mort leads end-to-end development of the GenPro Analytics™ platform. He is responsible for translating Dr.Marsh's research innovations into a secure and scalable platform that operates in a cloud environment to enables customer engagements. A hands-on, business-savvy, developer, innovator and leader, Mort codes, deftly defines architectures, contributes strategically, and drives operational efficiency.
Andrew is an experienced CFO with a proven record in entrepreneurial start-ups, emerging growth, and Fortune 500 businesses in the US and abroad. He leads finance and administrative functions. He has been a CFO in a number of industries - medical devices, life science, technology, banking, airlines, and education. He is a high-honors MBA from Northeastern University and earned his B.A. in Political Science/Economics from McGill University.
Ian WrightUnconfirmedTracy ShickelUnconfirmed